Title of article
Stenting the stent: initial results and long-term clinical and angiographic outcome of coronary stenting for patients with in-stent restenosis
Author/Authors
Alfonso، نويسنده , , Fernando and Cequier، نويسنده , , Angel and Zueco، نويسنده , , Javier and Mor??s، نويسنده , , César and Su?rez، نويسنده , , Concepci?n P and Colman، نويسنده , , Thierry and Esplugas، نويسنده , , Enrique and Pérez-Vizcayno، نويسنده , , Mar??a J and Fern?ndez، نويسنده , , Cristina and Macaya، نويسنده , , Carlos، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2000
Pages
6
From page
327
To page
332
Abstract
Stent restenosis constitutes a therapeutic challenge affecting an increasing number of patients. Conventional angioplasty and debulking techniques are currently used in these patients. However, the potential role of a second stent implantation in this setting (stenting the stent) remains unknown. Therefore, 65 consecutive patients (12 women, aged 62 ± 11 years) undergoing stent implantation (42 elective and 23 unplanned) for the treatment of in-stent restenosis (diffuse [>10 mm] in 39 [60%]) were studied. Angiographic success was obtained in all patients. Three patients developed hospital complications: 1 died from refractory heart failure and 2 suffered non–Q-wave myocardial infarctions. During follow-up (mean 17 ± 11 months) 1 patient died (noncardiac cause) and only 9 (14%) required target vessel revascularization. Kaplan-Meier event-free survival (freedom from death, myocardial infarction, and target vessel revascularization) at 1 year was 84%. Using Cox analysis, patients with unstable symptoms, a short time to stent restenosis, nonelective stenting, and B2-C lesions tended to have poorer prognosis. After adjustment, nonelective stenting was associated (adjusted RR 2.9, 95% confidence interval [CI] 0.82 to 10.3, p = 0.09) with an adverse clinical outcome. On quantitative angiography (core lab) restenosis was found in 13 of 43 patients (30%) (75% of those eligible). Logistic regression analysis identify restenosis length (adjusted RR 1.43, 95% CI 1.04 to 2.14, p = 0.04), and time to restenosis (adjusted RR 0.67, 95% CI 0.47 to 0.94, p = 0.01) as the only independent predictors of recurrent restenosis. Thus, repeat coronary stenting is a safe and efficacious strategy for the treatment of patients with in-stent restenosis. Both elective and nonelective stenting provide excellent initial results. The long-term clinical and angiographic outcome of these patients is also favorable.
Journal title
American Journal of Cardiology
Serial Year
2000
Journal title
American Journal of Cardiology
Record number
1891759
Link To Document